Evidence map›Paper›PMID 38172444›Full record

ReviewEuropean journal of pediatrics2024

Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany.

Maximilian David Mauritz, Ulrich von Both, Christian Dohna-Schwake, Christian Gille, Carola Hasan, Johannes Huebner, Markus Hufnagel, Markus Knuf, Johannes G Liese, Hanna Renk and 6 more

Open access · hybridAbstract readReview
In one paragraph

Review in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 1 country.

Maximilian David MauritzPaediatric Palliative Care Centre, Children's and Adolescents' Hospital, 45711, Datteln, Germany. m.mauritz@kinderklinik-datteln.de.ORCID http://orcid.org/0000-0002-9618-5307
Ulrich von BothDepartment of Infectious Diseases, Dr von Hauner Children's Hospital, LMU University Hospital, 80337, Munich, Germany.
Christian Dohna-SchwakeDepartment of Pediatrics I, Neonatology, Pediatric Intensive Care Medicine, and Pediatric Neurology, University Hospital Essen, 45147, Essen, Germany.
Christian GilleDepartment of Neonatology, Heidelberg University Children's Hospital, 69120, Heidelberg, Germany.
Carola HasanPaediatric Palliative Care Centre, Children's and Adolescents' Hospital, 45711, Datteln, Germany.
Johannes HuebnerDepartment of Infectious Diseases, Dr von Hauner Children's Hospital, LMU University Hospital, 80337, Munich, Germany.
Markus HufnagelDepartment of Paediatrics and Adolescent Medicine, Medical Faculty, University Medical Centre, University of Freiburg, 79106, Freiburg, Germany.
Markus KnufDepartment for Pediatric and Adolescent Medicine, Worms Clinic, 67550, Worms, Germany.
Johannes G LieseDepartment of Paediatrics, Division of Paediatric Infectious Diseases, University Hospital of Wuerzburg, 97080, Würzburg, Germany.
Hanna RenkUniversity Children's Hospital Tuebingen, 72076, Tuebingen, Germany.
Henriette RudolphDepartment of Pediatrics, Goethe University Frankfurt, 60590, Frankfurt am Main, Germany.
Ulf Schulze-SturmUniversity Children's Hospital, University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.
Arne SimonPediatric Oncology and Hematology, University Hospital Homburg Saar, 66421, Homburg/Saar, Germany.
Florian StehlingDepartment of Pediatric Pulmonology and Sleep Medicine, University Children's Hospital Essen, 45147, Essen, Germany.
Tobias TenenbaumClinic for Child and Adolescent Medicine, Sana Klinikum Lichtenberg, Academic Teaching Hospital, Charité-Universitätsmedizin, 10365, Berlin, Germany.
Boris ZernikowPaediatric Palliative Care Centre, Children's and Adolescents' Hospital, 45711, Datteln, Germany.
Witten/Herdecke University · DEEssen University Hospital · DELMU Klinikum · DEGoethe University Frankfurt · DEHeidelberg University · DESaarland University · DESana Klinikum Lichtenberg · DEUniversität Hamburg · DEUniversitätsklinikum Würzburg · DEUniversity Children's Hospital Tübingen · DEUniversity of Applied Sciences Worms · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children and adolescents with severe neurological impairment (SNI) require specialized care due to their complex medical needs. In particular, these patients are often affected by severe and recurrent lower respiratory tract infections (LRTIs). These infections, including viral and bacterial etiology, pose a significant risk to these patients, often resulting in respiratory insufficiency and long-term impairments. Using expert consensus, we developed clinical recommendations on the management of LRTIs in children and adolescents with SNI. These recommendations emphasize comprehensive multidisciplinary care and antibiotic stewardship. Initial treatment should involve symptomatic care, including hydration, antipyretics, oxygen therapy, and respiratory support. In bacterial LRTIs, antibiotic therapy is initiated based on the severity of the infection, with aminopenicillin plus a beta-lactamase inhibitor recommended for community-acquired LRTIs and piperacillin-tazobactam for patients with chronic lung disease or tracheostomy. Ongoing management includes regular evaluations, adjustments to antibiotic therapy based on pathogen identification, and optimization of supportive care. Implementation of these recommendations aims to improve the diagnosis and treatment of LRTIs in children and adolescents with SNI. What is Known: • Children and adolescents with severe neurological impairment are particularly affected by severe and recurrent lower respiratory tract infections (LRTIs). • The indication and choice of antibiotic therapy for bacterial LRTI is often difficult because there are no evidence-based treatment recommendations for this heterogeneous but vulnerable patient population; the frequent overuse of broad-spectrum or reserve antibiotics in this patient population increases selection pressure for multidrug-resistant pathogens. What is New: • The proposed recommendations provide a crucial framework for focused diagnostics and treatment of LRTIs in children and adolescents with severe neurological impairment. • Along with recommendations for comprehensive and multidisciplinary therapy and antibiotic stewardship, ethical and palliative care aspects are taken into account.

Indexed as

Bacterial InfectionsRespiratory Tract InfectionsAdolescentAnti-Bacterial AgentsBacteriaChildHumansInpatientsPiperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsPiperacillin, Tazobactam Drug CombinationAntimicrobial stewardshipLower respiratory tract infectionsPneumoniaSevere neurological impairment

Identifiers

PMID38172444
PMCPMC10951000
OpenAlexW4390547089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.